On the other hand, the MGMT promoter genotypes and methylation were not associated with prolonged OSTs in all glioma patients without TMZ treatment (S4 and S5B Figs), except the LGGs patients having CC genotypes (S5A Fig). This evidence concerns the gene MGMT and central nervous system cancer.